Skip to content

Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis Patients

Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis Patients

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01201343
Acronym
SEPTIME
Enrollment
79
Registered
2010-09-14
Start date
2005-01-31
Completion date
2010-07-31
Last updated
2013-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis, Relapsing, Remitting

Keywords

Multiple sclerosis, relapsing, remitting, Interferon-beta

Brief summary

This study is planned to evaluate emotional disorders during treatment by interferon (IFN) beta in relapsing remitting multiple sclerosis (RRMS) subjects. This is an open-label exploratory study with no change of therapeutic behavior but with standardized neuropsychologic follow-up.

Detailed description

This study is planned to evaluate emotional disorders during treatment by IFN beta in RRMS subjects. This is an open-label, prospective, interventional, multicentric study with no change of therapeutic behavior but with standardized neuropsychologic follow-up. Subjects will undergo 13 evaluations (categorical and dimensional evaluations), 3 evaluations will be performed before the treatment (Baseline, Day 7 and 15) and 10 evaluations after the treatment (Month 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24).

Interventions

DRUGInterferon beta-1a

Sponsors

Merck Serono S.A.S, France
CollaboratorINDUSTRY
Merck KGaA, Darmstadt, Germany
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male and female subjects aged ≥ 18 years * Subjects with RRMS * Subjects with at least 2 relapses in the past two years (with last relapse finished or finishing) * Subjects with indication of IFN beta treatment determined by the investigator * Other protocol-defined inclusion criteria may apply

Exclusion criteria

* Subjects with secondary progressive multiple sclerosis (MS) without relapse * Subjects with ongoing acute relapse * Subjects already being treated with interferon * Subjects with corticoid therapy for less than 15 days * Subjects presenting acute major depression or treated with anti-depressant therapy * Subjects involved in another therapeutic study * Subjects with any condition which could interfere with a good compliance of this study * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in Emotional Dyscontrol Sub-score of the Depressive Mood Scale (Echelle d'Humeur Depressive [EHD]) Scale at Month 12Baseline and Month 12EHD scale is a tool to assess the depressive mood dimensions 'lack of emotional control' (emotional dyscontrol) and 'blunted effect' which comprises of 11 items graded in 4 degrees from 1 (not at all) to 4 (very much), where 4 corresponds to the worst state. The emotional dyscontrol sub-score is the sum of items 1, 2, 4, 5, 9, 10, and 11. The total possible score range from 1 (not at all) to 28 (very much), where 28 corresponds to worst state. (Radat F et al., 2007)
Change From Baseline in Emotional Dyscontrol Sub-score of the EHD Scale at Month 18Baseline and Month 18EHD scale is a tool to assess the depressive mood dimensions 'lack of emotional control' (emotional dyscontrol) and 'blunted effect' which comprises of 11 items graded in 4 degrees from 1 (not at all) to 4 (very much), where 4 corresponds to the worst state. The emotional dyscontrol sub-score is the sum of items 1, 2, 4, 5, 9, 10, and 11. The total possible score range from 1 (not at all) to 28 (very much), where 28 corresponds to worst state. (Radat F et al., 2007)
Change From Baseline in Emotional Dyscontrol Sub-score of the EHD Scale at Month 24Baseline and Month 24EHD scale is a tool to assess the depressive mood dimensions 'lack of emotional control' (emotional dyscontrol) and 'blunted effect' which comprises of 11 items graded in 4 degrees from 1 (not at all) to 4 (very much), where 4 corresponds to the worst state. The emotional dyscontrol sub-score is the sum of items 1, 2, 4, 5, 9, 10, and 11. The total possible score range from 1 (not at all) to 28 (very much), where 28 corresponds to worst state. (Radat F et al., 2007)

Secondary

MeasureTime frameDescription
Change From Baseline in Center for State-trait Anger Expression Inventory 2 (STAXI-state) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Baseline, Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24STAXI-state scale measures the intensity of anger as an emotional state (state anger) and the disposition to experience angry feelings as a personality trait (trait anger). In this study only 1 of the original 6 scales was used, the state anger scale, which measures the intensity of anger at a given moment as emotional state. This scale consists of 15 items graded in 4 degrees from 1 (not at all) to 4 (very much), where 4 corresponds to the worst state. The total score range from 1 (not at all) to 60 (very much), where 60 corresponds to the worst state. (Spielberger CD, 1996)
Change From Baseline in Emotional Abrasion Sub-score of the EHD Scale at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Baseline, Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24EHD scale is a tool to assess the depressive mood dimensions 'lack of emotional control' (emotional dyscontrol) and 'blunted effect' which comprises of 11 items graded in 4 degrees from 1 (not at all) to 4 (very much), where 4 corresponds to the worst state. The emotional abrasion sub-score is the sum of items 3, 6, 7, and 8. The total possible score range from 1 (not at all) to 16 (very much), where 16 corresponds to worst state. (Radat F et al., 2007)
Change From Baseline in Fatigue Score at Months 1, 2, 3, 6, 12 and 24Baseline, Months 1, 2, 3, 6, 12, and 24Fatigue scale was derived from the United Kingdom Neurological Disability Scale (UKNDS), and evaluates fatigue according to the participant's subjective impression and the functional disability that it causes. 'Yes' or 'No' answers result in a score that ranges from 0 to 5, where a score 5 shows worse state. (Sharrack B et al., 1999)
Change From Baseline in State-trait Anxiety Inventory (STAI State) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Baseline, Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24STAI state scale is an auto-evaluation scale for anxiety. This scale includes 20 items that allow quantifying feeling of apprehension, tension, nervousness and worry that the participant feels at the time of the completion of the questionnaire. The 20 items are graded from 1 (no) to 4 (yes), where 'yes' corresponds to the best state for items 1, 2, 5, 8, 10, 11, 15, 16, 19, 20 (scoring was reversed before calculation of total score); and to the worst state for items 3, 4, 6, 7, 9, 12, 13, 14, 17, 18. The total score ranged from 1 (best state) to 80 (worst state). (Spielberger CD et al., 1983)
Change From Baseline in Center for Epidemiologic Studies Depression (CES-D) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Baseline, Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24CES-D is an auto-questionnaire including 20 items to screen for depressive feelings and behaviour. The 20 items of this scale are graded from 0 (never) to 3 (always), where 3 corresponds to the most severe state with the exception of items 4, 8, 12 and 16 (scoring was reversed before the calculation of the total score). Total score ranged from 0 (never) to 60 (always), where 60 corresponds to most severe state. (Radloff LS, 1977)

Participant flow

Participants by arm

ArmCount
Interferon-beta
Participants received interferon-beta based on investigator's discretion as per the clinical practice for 2 years.
70
Total70

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAdverse Event6
Overall StudyLack of Efficacy2
Overall StudyLost to Follow-up2
Overall StudyParticipant wrongly included in trial1
Overall StudyRandomized, not treated3
Overall StudyWithdrawal by Subject5

Baseline characteristics

CharacteristicInterferon-beta
Age, Continuous37.0 years
STANDARD_DEVIATION 11.5
Sex: Female, Male
Female
56 Participants
Sex: Female, Male
Male
14 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
62 / 76
serious
Total, serious adverse events
9 / 76

Outcome results

Primary

Change From Baseline in Emotional Dyscontrol Sub-score of the Depressive Mood Scale (Echelle d'Humeur Depressive [EHD]) Scale at Month 12

EHD scale is a tool to assess the depressive mood dimensions 'lack of emotional control' (emotional dyscontrol) and 'blunted effect' which comprises of 11 items graded in 4 degrees from 1 (not at all) to 4 (very much), where 4 corresponds to the worst state. The emotional dyscontrol sub-score is the sum of items 1, 2, 4, 5, 9, 10, and 11. The total possible score range from 1 (not at all) to 28 (very much), where 28 corresponds to worst state. (Radat F et al., 2007)

Time frame: Baseline and Month 12

Population: Intent-to-treat (ITT) population: all participants with at least 1 interferon-beta intake and 1 evaluation of primary criterion, that is, at least 1 evaluation before treatment initiation and after Day 0 for emotional dyscontrol sub-score. 'n' signifies those participants who were evaluated for this measure at that time point.

ArmMeasureGroupValue (MEAN)Dispersion
Interferon-betaChange From Baseline in Emotional Dyscontrol Sub-score of the Depressive Mood Scale (Echelle d'Humeur Depressive [EHD]) Scale at Month 12Change at Month 12 (n= 57)-0.5 units on a scaleStandard Deviation 4.2
Interferon-betaChange From Baseline in Emotional Dyscontrol Sub-score of the Depressive Mood Scale (Echelle d'Humeur Depressive [EHD]) Scale at Month 12Baseline (n= 70)12.7 units on a scaleStandard Deviation 4.4
Primary

Change From Baseline in Emotional Dyscontrol Sub-score of the EHD Scale at Month 18

EHD scale is a tool to assess the depressive mood dimensions 'lack of emotional control' (emotional dyscontrol) and 'blunted effect' which comprises of 11 items graded in 4 degrees from 1 (not at all) to 4 (very much), where 4 corresponds to the worst state. The emotional dyscontrol sub-score is the sum of items 1, 2, 4, 5, 9, 10, and 11. The total possible score range from 1 (not at all) to 28 (very much), where 28 corresponds to worst state. (Radat F et al., 2007)

Time frame: Baseline and Month 18

Population: ITT population: all participants with at least 1 interferon-beta intake and 1 evaluation of primary criterion, that is, at least 1 evaluation before treatment initiation and after Day 0 for emotional dyscontrol sub-score. 'N' (number of participants analyzed) signifies those participants who were evaluated for this measure at that time-point.

ArmMeasureValue (MEAN)Dispersion
Interferon-betaChange From Baseline in Emotional Dyscontrol Sub-score of the EHD Scale at Month 18-0.6 units on a scaleStandard Deviation 4.6
Primary

Change From Baseline in Emotional Dyscontrol Sub-score of the EHD Scale at Month 24

EHD scale is a tool to assess the depressive mood dimensions 'lack of emotional control' (emotional dyscontrol) and 'blunted effect' which comprises of 11 items graded in 4 degrees from 1 (not at all) to 4 (very much), where 4 corresponds to the worst state. The emotional dyscontrol sub-score is the sum of items 1, 2, 4, 5, 9, 10, and 11. The total possible score range from 1 (not at all) to 28 (very much), where 28 corresponds to worst state. (Radat F et al., 2007)

Time frame: Baseline and Month 24

Population: ITT population: all participants with at least 1 interferon-beta intake and 1 evaluation of primary criterion, that is, at least 1 evaluation before treatment initiation and after Day 0 for emotional dyscontrol sub-score. 'N' (number of participants analyzed) signifies those participants who were evaluated for this measure at that time-point.

ArmMeasureValue (MEAN)Dispersion
Interferon-betaChange From Baseline in Emotional Dyscontrol Sub-score of the EHD Scale at Month 24-0.1 units on a scaleStandard Deviation 5.2
Secondary

Change From Baseline in Center for Epidemiologic Studies Depression (CES-D) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24

CES-D is an auto-questionnaire including 20 items to screen for depressive feelings and behaviour. The 20 items of this scale are graded from 0 (never) to 3 (always), where 3 corresponds to the most severe state with the exception of items 4, 8, 12 and 16 (scoring was reversed before the calculation of the total score). Total score ranged from 0 (never) to 60 (always), where 60 corresponds to most severe state. (Radloff LS, 1977)

Time frame: Baseline, Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24

Population: ITT population: all participants with at least 1 interferon-beta intake and 1 evaluation of primary criterion, that is, at least 1 evaluation before treatment initiation and after Day 0 for emotional dyscontrol sub-score. 'n' signifies those participants who were evaluated for this measure at that time point.

ArmMeasureGroupValue (MEAN)Dispersion
Interferon-betaChange From Baseline in Center for Epidemiologic Studies Depression (CES-D) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Baseline (n= 70)13.5 units on a scaleStandard Deviation 11.1
Interferon-betaChange From Baseline in Center for Epidemiologic Studies Depression (CES-D) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 24 (n= 63)0.1 units on a scaleStandard Deviation 10.1
Interferon-betaChange From Baseline in Center for Epidemiologic Studies Depression (CES-D) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 1 (n= 65)1.0 units on a scaleStandard Deviation 8.6
Interferon-betaChange From Baseline in Center for Epidemiologic Studies Depression (CES-D) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 2 (n= 62)1.5 units on a scaleStandard Deviation 10.6
Interferon-betaChange From Baseline in Center for Epidemiologic Studies Depression (CES-D) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 3 (n= 64)-0.5 units on a scaleStandard Deviation 9.9
Interferon-betaChange From Baseline in Center for Epidemiologic Studies Depression (CES-D) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 4 (n= 58)-1.0 units on a scaleStandard Deviation 9.8
Interferon-betaChange From Baseline in Center for Epidemiologic Studies Depression (CES-D) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 5 (n= 58)-1.1 units on a scaleStandard Deviation 8.6
Interferon-betaChange From Baseline in Center for Epidemiologic Studies Depression (CES-D) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 6 (n= 56)0.9 units on a scaleStandard Deviation 9.2
Interferon-betaChange From Baseline in Center for Epidemiologic Studies Depression (CES-D) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 9 (n= 58)0.9 units on a scaleStandard Deviation 10.7
Interferon-betaChange From Baseline in Center for Epidemiologic Studies Depression (CES-D) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 12 (n= 57)1.6 units on a scaleStandard Deviation 10.8
Interferon-betaChange From Baseline in Center for Epidemiologic Studies Depression (CES-D) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 18 (n= 61)-0.2 units on a scaleStandard Deviation 9
Secondary

Change From Baseline in Center for State-trait Anger Expression Inventory 2 (STAXI-state) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24

STAXI-state scale measures the intensity of anger as an emotional state (state anger) and the disposition to experience angry feelings as a personality trait (trait anger). In this study only 1 of the original 6 scales was used, the state anger scale, which measures the intensity of anger at a given moment as emotional state. This scale consists of 15 items graded in 4 degrees from 1 (not at all) to 4 (very much), where 4 corresponds to the worst state. The total score range from 1 (not at all) to 60 (very much), where 60 corresponds to the worst state. (Spielberger CD, 1996)

Time frame: Baseline, Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24

Population: ITT population: all participants with at least 1 interferon-beta intake and 1 evaluation of primary criterion, that is, at least 1 evaluation before treatment initiation and after Day 0 for emotional dyscontrol sub-score. 'n' signifies those participants who were evaluated for this measure at that time point.

ArmMeasureGroupValue (MEAN)Dispersion
Interferon-betaChange From Baseline in Center for State-trait Anger Expression Inventory 2 (STAXI-state) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Baseline (n= 70)16.8 units on a scaleStandard Deviation 4.1
Interferon-betaChange From Baseline in Center for State-trait Anger Expression Inventory 2 (STAXI-state) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 1 (n= 65)0.0 units on a scaleStandard Deviation 4.2
Interferon-betaChange From Baseline in Center for State-trait Anger Expression Inventory 2 (STAXI-state) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 4 (n= 59)-0.3 units on a scaleStandard Deviation 4.7
Interferon-betaChange From Baseline in Center for State-trait Anger Expression Inventory 2 (STAXI-state) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 5 (n= 58)-0.0 units on a scaleStandard Deviation 2.9
Interferon-betaChange From Baseline in Center for State-trait Anger Expression Inventory 2 (STAXI-state) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 24 (n= 63)1.0 units on a scaleStandard Deviation 5.5
Interferon-betaChange From Baseline in Center for State-trait Anger Expression Inventory 2 (STAXI-state) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 2 (n= 62)1.0 units on a scaleStandard Deviation 5.3
Interferon-betaChange From Baseline in Center for State-trait Anger Expression Inventory 2 (STAXI-state) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 3 (n= 64)-0.0 units on a scaleStandard Deviation 5.3
Interferon-betaChange From Baseline in Center for State-trait Anger Expression Inventory 2 (STAXI-state) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 6 (n= 56)1.1 units on a scaleStandard Deviation 7.6
Interferon-betaChange From Baseline in Center for State-trait Anger Expression Inventory 2 (STAXI-state) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 9 (n= 58)1.1 units on a scaleStandard Deviation 5.9
Interferon-betaChange From Baseline in Center for State-trait Anger Expression Inventory 2 (STAXI-state) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 12 (n= 57)0.9 units on a scaleStandard Deviation 5.7
Interferon-betaChange From Baseline in Center for State-trait Anger Expression Inventory 2 (STAXI-state) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 18 (n= 61)0.8 units on a scaleStandard Deviation 5.4
Secondary

Change From Baseline in Emotional Abrasion Sub-score of the EHD Scale at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24

EHD scale is a tool to assess the depressive mood dimensions 'lack of emotional control' (emotional dyscontrol) and 'blunted effect' which comprises of 11 items graded in 4 degrees from 1 (not at all) to 4 (very much), where 4 corresponds to the worst state. The emotional abrasion sub-score is the sum of items 3, 6, 7, and 8. The total possible score range from 1 (not at all) to 16 (very much), where 16 corresponds to worst state. (Radat F et al., 2007)

Time frame: Baseline, Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24

Population: ITT population: all participants with at least 1 interferon-beta intake and 1 evaluation of primary criterion, that is, at least 1 evaluation before treatment initiation and after Day 0 for emotional dyscontrol sub-score. 'n' signifies those participants who were evaluated for this measure at that time point.

ArmMeasureGroupValue (MEAN)Dispersion
Interferon-betaChange From Baseline in Emotional Abrasion Sub-score of the EHD Scale at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Baseline (n= 70)5.6 units on a scaleStandard Deviation 1.6
Interferon-betaChange From Baseline in Emotional Abrasion Sub-score of the EHD Scale at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 1 (n= 64)0.3 units on a scaleStandard Deviation 1.6
Interferon-betaChange From Baseline in Emotional Abrasion Sub-score of the EHD Scale at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 2 (n= 62)-0.1 units on a scaleStandard Deviation 1.7
Interferon-betaChange From Baseline in Emotional Abrasion Sub-score of the EHD Scale at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 3 (n= 64)-0.0 units on a scaleStandard Deviation 1.6
Interferon-betaChange From Baseline in Emotional Abrasion Sub-score of the EHD Scale at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 12 (n= 57)-0.0 units on a scaleStandard Deviation 2.3
Interferon-betaChange From Baseline in Emotional Abrasion Sub-score of the EHD Scale at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 18 (n= 61)-0.3 units on a scaleStandard Deviation 1.9
Interferon-betaChange From Baseline in Emotional Abrasion Sub-score of the EHD Scale at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 24 (n= 63)-0.3 units on a scaleStandard Deviation 1.7
Interferon-betaChange From Baseline in Emotional Abrasion Sub-score of the EHD Scale at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 4 (n= 59)-0.0 units on a scaleStandard Deviation 1.8
Interferon-betaChange From Baseline in Emotional Abrasion Sub-score of the EHD Scale at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 5 (n= 58)-0.2 units on a scaleStandard Deviation 1.5
Interferon-betaChange From Baseline in Emotional Abrasion Sub-score of the EHD Scale at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 6 (n= 56)-0.3 units on a scaleStandard Deviation 1.8
Interferon-betaChange From Baseline in Emotional Abrasion Sub-score of the EHD Scale at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 9 (n= 58)-0.1 units on a scaleStandard Deviation 1.8
Secondary

Change From Baseline in Fatigue Score at Months 1, 2, 3, 6, 12 and 24

Fatigue scale was derived from the United Kingdom Neurological Disability Scale (UKNDS), and evaluates fatigue according to the participant's subjective impression and the functional disability that it causes. 'Yes' or 'No' answers result in a score that ranges from 0 to 5, where a score 5 shows worse state. (Sharrack B et al., 1999)

Time frame: Baseline, Months 1, 2, 3, 6, 12, and 24

Population: ITT population. 'N' (number of participants analyzed) signifies those participants who were evaluated for this measure. 'n' signifies those participants who were evaluated for this measure at that time point.

ArmMeasureGroupValue (MEAN)Dispersion
Interferon-betaChange From Baseline in Fatigue Score at Months 1, 2, 3, 6, 12 and 24Baseline (n= 62)2.1 units on a scaleStandard Deviation 1.7
Interferon-betaChange From Baseline in Fatigue Score at Months 1, 2, 3, 6, 12 and 24Change at Month 1 (n= 58)0.5 units on a scaleStandard Deviation 1.6
Interferon-betaChange From Baseline in Fatigue Score at Months 1, 2, 3, 6, 12 and 24Change at Month 2 (n= 55)0.4 units on a scaleStandard Deviation 1.5
Interferon-betaChange From Baseline in Fatigue Score at Months 1, 2, 3, 6, 12 and 24Change at Month 12 (n= 49)0.1 units on a scaleStandard Deviation 1.8
Interferon-betaChange From Baseline in Fatigue Score at Months 1, 2, 3, 6, 12 and 24Change at Month 24 (n= 56)-0.1 units on a scaleStandard Deviation 2.1
Interferon-betaChange From Baseline in Fatigue Score at Months 1, 2, 3, 6, 12 and 24Change at Month 3 (n= 56)0.2 units on a scaleStandard Deviation 1.8
Interferon-betaChange From Baseline in Fatigue Score at Months 1, 2, 3, 6, 12 and 24Change at Month 6 (n= 50)0.4 units on a scaleStandard Deviation 1.8
Secondary

Change From Baseline in State-trait Anxiety Inventory (STAI State) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24

STAI state scale is an auto-evaluation scale for anxiety. This scale includes 20 items that allow quantifying feeling of apprehension, tension, nervousness and worry that the participant feels at the time of the completion of the questionnaire. The 20 items are graded from 1 (no) to 4 (yes), where 'yes' corresponds to the best state for items 1, 2, 5, 8, 10, 11, 15, 16, 19, 20 (scoring was reversed before calculation of total score); and to the worst state for items 3, 4, 6, 7, 9, 12, 13, 14, 17, 18. The total score ranged from 1 (best state) to 80 (worst state). (Spielberger CD et al., 1983)

Time frame: Baseline, Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24

Population: ITT population: all participants with at least 1 interferon-beta intake and 1 evaluation of primary criterion, that is, at least 1 evaluation before treatment initiation and after Day 0 for emotional dyscontrol sub-score. 'n' signifies those participants who were evaluated for this measure at that time point.

ArmMeasureGroupValue (MEAN)Dispersion
Interferon-betaChange From Baseline in State-trait Anxiety Inventory (STAI State) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Baseline (n= 70)35.9 units on a scaleStandard Deviation 11.8
Interferon-betaChange From Baseline in State-trait Anxiety Inventory (STAI State) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 1 (n= 65)0.8 units on a scaleStandard Deviation 10.5
Interferon-betaChange From Baseline in State-trait Anxiety Inventory (STAI State) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 2 (n= 62)0.3 units on a scaleStandard Deviation 12.3
Interferon-betaChange From Baseline in State-trait Anxiety Inventory (STAI State) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 3 (n= 64)-1.7 units on a scaleStandard Deviation 11.5
Interferon-betaChange From Baseline in State-trait Anxiety Inventory (STAI State) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 5 (n= 58)-0.8 units on a scaleStandard Deviation 9.2
Interferon-betaChange From Baseline in State-trait Anxiety Inventory (STAI State) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 6 (n= 55)-1.4 units on a scaleStandard Deviation 11.5
Interferon-betaChange From Baseline in State-trait Anxiety Inventory (STAI State) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 18 (n= 61)-1.2 units on a scaleStandard Deviation 11.2
Interferon-betaChange From Baseline in State-trait Anxiety Inventory (STAI State) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 24 (n= 63)-1.4 units on a scaleStandard Deviation 13.1
Interferon-betaChange From Baseline in State-trait Anxiety Inventory (STAI State) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 4 (n= 59)-1.5 units on a scaleStandard Deviation 11
Interferon-betaChange From Baseline in State-trait Anxiety Inventory (STAI State) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 9 (n= 58)-0.2 units on a scaleStandard Deviation 10.5
Interferon-betaChange From Baseline in State-trait Anxiety Inventory (STAI State) Score at Months 1, 2, 3, 4, 5, 6, 9, 12, 18 and 24Change at Month 12 (n= 57)-0.3 units on a scaleStandard Deviation 12.7

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026